The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

Cancerguard by Exact Sciences is the first of its kind early detection blood test for multiple kinds of cancer. Exact Sciences is a diagnostic company focusing on early cancer detection. Cancerguard ...

Breast cancer remains one of the most prevalent and emotionally fraught diagnoses in medicine. Cases of female breast cancer look set to to rise by 38% worldwide over the next 25 years, while deaths ...

Last September, a seemingly innocuous announcement from the US Food and Drug Administration (FDA) created a swell of confusion for 42 million women. The agency updated its Mammography Quality ...

Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all Americans Program to deliver first-in-class synthetic-sensor based MCED test for Stage I detection of 30+ solid ...

The study evaluated the Galleri® MCED test across a large cohort of 111,080 participants in real-world healthcare settings, ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...

A new type of blood test could help detect multiple cancers early. A team of researchers in California studied a new multi-cancer early detection (MCED) test called Galleri, which can reportedly ...

India has the highest global mortality rate for breast cancer. This isn’t an outlandish claim, but reality backed by multiple studies across the globe. The studies spanned over decades, but India has ...